Infinity Pharma adds another bull at JPMorgan on potential of cancer therapy
Infinity Pharmaceuticals (INFI) has climbed ~17.9% in the pre-market after JP Morgan upgraded the stock to overweight from neutral,…
Seeking Alpha
Insider Weekends: Landis Martin Continues His Purchases Of Crown Castle International
Insider buying decreased last week. Selling also decreased significantly. Click here to read about the notable buys and sells…
UMH Properties: Underappreciated Growth Prospects Make This Company A Strong Buy
The manufactured housing industry has entered a period of sustainable growth. I view the company as a solid long-term holding…
Why I Sold Par Pacific Holdings
Par Pacific was initially intriguing as a niche oil refiner with unheralded positions in Hawaii and Wyoming (and now Washington)….
Pinterest 25% Down: Social Media 2.0 Is Misunderstood
If you look at ARPU and you look at which users Pinterest lost, I think you can only be happy with the results. ARPU is the driving…
NV Bekaert SA (BEKSF) CEO Oswald Schmid on Q2 2021 Results – Earnings Call Transcript
NV Bekaert SA (OTC:BEKSF) Q2 2021 Earnings Conference Call July 30, 2021 8:00 AM ETCompany ParticipantsKatelijn Bohez – Investor…
Weekly Market Pulse: Trading Places
Stocks are expensive, and people aren’t buying because they want to but because they feel like they have to. This panicky behavior…
Kadmon: What Will Lead To A Short Squeeze
Kadmon hasn’t done as well as it should despite an approval. The criminal pasts of its founders has been used as a way to keep…
STK: Hedging And Yield Spread Analysis
This article performs a closer examination of STK in terms of income, growth, and volatility to further examine its pros and…
Ipsen S.A. (IPSEY) CEO Francesco Caio on Q2 2021 Results – Earnings Call Transcript
Ipsen S.A. (OTCPK:IPSEY) Q2 2021 Earnings Conference Call July 29, 2021 8:30 AM ETCompany ParticipantsDavid Loew – CEOAymeric…